Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Inventory Average of $957.9 million for Q1 2026, up 13.27% year-over-year from $845.7 million in Q1 2025, and down 3.82% quarter-over-quarter from $996.0 million in Q4 2025.
Sarepta Therapeutics (SRPT) Inventory Average (2016 - 2026) Analysis & Trends
Sarepta Therapeutics' Inventory Average history runs 11 years deep, the most recent figure standing at $957.9 million for Q1 2026.
- In Q1 2026, Inventory Average rose 13.27% year-over-year to $957.9 million; the TTM figure through Mar 2026 stood at $957.9 million (up 13.27% YoY), while the FY2025 annual figure was $832.4 million, up 55.17% from the prior year.
- Inventory Average for Q1 2026 stood at $957.9 million, down from $996.0 million in the prior quarter.
- The five-year high for Inventory Average was $1.0 billion in Q3 2025, with the low at $192.6 million in Q1 2022.
- The 5-year median for Inventory Average is $348.2 million (2024), against an average of $501.5 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average retreated 22.96% in 2022, then jumped 142.88% in 2025.
- Sarepta Therapeutics' Inventory Average stood at $212.6 million in 2022, then soared by 33.33% to $283.4 million in 2023, then surged by 132.13% to $657.9 million in 2024, then surged by 51.37% to $996.0 million in 2025, then retreated by 3.82% to $957.9 million in 2026.
- Business Quant data shows SRPT's Inventory Average at $957.9 million in Q1 2026, $996.0 million in Q4 2025, and $1.0 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 952.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 952.69 Mn |
| Mar 31, 2026 | 957.93 Mn |
| Dec 31, 2025 | 995.96 Mn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 967.73 Mn |
| Mar 31, 2025 | 845.70 Mn |
| Dec 31, 2024 | 657.94 Mn |
| Sep 30, 2024 | 525.86 Mn |
| Jun 30, 2024 | 429.66 Mn |
| Mar 31, 2024 | 348.19 Mn |
| Dec 31, 2023 | 283.44 Mn |
| Sep 30, 2023 | 235.44 Mn |
| Jun 30, 2023 | 214.78 Mn |
| Mar 31, 2023 | 203.32 Mn |
| Dec 31, 2022 | 212.58 Mn |
| Sep 30, 2022 | 214.64 Mn |
| Jun 30, 2022 | 203.55 Mn |
| Mar 31, 2022 | 192.60 Mn |
| Dec 31, 2021 | 237.34 Mn |
| Sep 30, 2021 | 278.61 Mn |